GlassScriptPhysician profile
David A Tendler
NPI 1811957731
$1,783.24
in general payments reported to CMS, 2019-2025
18 companies · $339 in 2025
The $339 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $692 · 2020: $132 · 2023: $284 · 2024: $337 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876 · Education: $84.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.13 |
| Education | $84.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $673.07 | 2019-2025 | Rinvoq, Skyrizi, Viberzi |
| Pfizer INC. | $238.63 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $197.55 | 2019-2020 | |
| Ucb, INC. | $118.80 | 2019-2020 | |
| Janssen Biotech, INC. | $95.58 | 2019-2025 | Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $83.99 | 2019-2020 | |
| Aimmune Therapeutics, INC. | $48.81 | 2024 | |
| Janssen Pharmaceuticals, INC | $48.18 | 2019 | |
| Intercept Pharmaceuticals, INC. | $44.89 | 2019-2020 | |
| Qol Medical, LLC | $44.48 | 2019 | |
| Celgene Corporation | $36.78 | 2023 | Zeposia |
| Phathom Pharmaceuticals, INC. | $33.99 | 2024 | Voquezna |
| Gilead Sciences, INC. | $27.68 | 2019 | |
| Genzyme Corporation | $24.99 | 2025 | |
| Novo Nordisk INC | $23.97 | 2025 | Wegovy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.94 | 2019 | |
| Ironwood Pharmaceuticals, INC | $13.96 | 2019 | |
| Allergan, INC. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tendler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.